Test Code WAGDR Alpha Globin Cluster Locus Deletion/Duplication, Blood
Ordering Guidance
Sequence variants, other than the alpha T-Saudi and hemoglobin Constant Spring alterations, are not detected by this assay. For detection of single point and other nondeletion variants, order WASEQ / Alpha Globin Gene Sequencing, Varies, if clinically indicated.
Shipping Instructions
Specimen Required
Patient Preparation: A previous bone marrow transplant from an allogeneic donor will interfere with testing. For instructions for testing patients who have received a bone marrow transplant, call 800-533-1710.
Specimen Type: Whole blood
Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Yellow top (ACD)
Specimen Volume: 3 mL
Collection Instructions:
1. Invert several times to mix blood.
2. Send whole blood specimen in original tube. Do not aliquot.
Forms
1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available in Special Instructions:
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing-Spanish (T826)
2. Molecular Genetics: Congenital Inherited Diseases Patient Information (T521)
Secondary ID
621361Useful For
Diagnosis of alpha-thalassemia
Carrier screening for individuals from high-risk populations for alpha-thalassemia
This test is not useful for diagnosis or confirmation of beta-thalassemia or hemoglobinopathies.
Special Instructions
Method Name
Dosage Analysis by Polymerase Chain Reaction (PCR)/Quantitative Polymerase Chain Reaction (qPCR)/Multiplex Ligation-Dependent Probe Amplification (MLPA)
Specimen Type
VariesSpecimen Minimum Volume
Blood: 1 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Varies | Varies |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Reference Values
An interpretive report will be provided.
Interpretation
The interpretive report includes an overview of the findings as well as the associated clinical significance.
Method Description
This test is a direct variant analysis assay. Deletions and duplications within the alpha-globin locus are identified by a multiplex ligation-dependent probe amplification assay. Thirty-three probes that hybridize throughout the alpha-globin locus from the HS40 promoter region through the 3'HVR region are utilized in order to maximize the information needed to map the approximate location of nearly all DNA deletions that occur. A quantitative polymerase chain reaction-based assay is used to detect the presence of hemoglobin Constant Spring (HBA2: c.427T >C) and alphaT-Saudi (HBA2: c.*94A>G) point mutations. In addition, a polymerase chain reaction-based assay is used to detect the presence of the alpha-3.7 and alpha-4.2 deletions.(Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30[12]:e57. doi:10.1093/nar/gnf056)
Day(s) Performed
Varies
Report Available
9 to 13 daysSpecimen Retention Time
2 weeks (if available)Performing Laboratory

CPT Code Information
81269
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
WAGDR | Alpha Globin Clustr Locus Del/Dup,B | 90040-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
621362 | Result Summary | 50397-9 |
621363 | Result | 82939-0 |
621364 | Interpretation | 69047-9 |
621365 | Additional Information | 48767-8 |
621366 | Specimen | 31208-2 |
621367 | Source | 31208-2 |
621368 | Method | 85069-3 |
621804 | Disclaimer | 62364-5 |
621369 | Released By | 18771-6 |